Chronic Hepatitis Infected with Hepatitis GB Virus Type C/Hepatitis G Virus Presenting as Non-Alcoholic Steatohepatitis

Internal Medicine

Volumn 36, Issue 4, 1997, Pages 283-288

  Saito, Hidetsugu ^a   Ebinuma, Hirotoshi ^a   Kuramochi, Shigeru ^a   Ishii, Hiromasa ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Alcoholic hepatitis; Atypical pneumonia; Liver biopsy; Reverse transcription polymerase chain reaction

Indexed keywords

AGED; ALCOHOL LIVER DISEASE; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; FLAVIVIRUS; GENETIC TRANSCRIPTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PATHOGENICITY; PATHOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY;

AGED; FLAVIVIRIDAE; HEPACIVIRUS; HEPATITIS C; HEPATITIS, ALCOHOLIC; HEPATITIS, CHRONIC; HUMANS; MALE; POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 0031114243     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.283     Document Type: Article

References (47)

1. Muerhoff AS, Leary TP, Simons JN, et al. Genomic organization of GB viruses A and B: two new members of the flaviviridae associated with GB agent hepatitis. J Virol 69: 5621, 1995.
2. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1: 564, 1995.
3. Ohba K, Mizokami M, Lau JY, Orito E, Ikeo K, Gojobori T. Evolutionary relationship of hepatitis C, pesti-, flavi-, plantviruses, and newly discovered GB hepatitis agents. FEBS Lett 378: 232, 1996.
4. Yoshida M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 346: 1131, 1995.
5. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 334: 195, 1996.
6. Nübling CM, Löwer J. GB-C genomes in a high-risk group, in plasma pools, and intravenous immunoglobulin. Lancet 347: 68, 1996.
7. Orito E, Mizokami M, Nakao T, et al. GB virus C/hepatitis G virus infection among Japanese patients with chronic liver diseases and blood donors. Virus Res (in press).
8. Lieber CS. Medical disorders of alcoholism. N Engl J Med 333: 1058, 1995.
9. International Group. Review of alcoholic liver disease morphological manifestations. Lancet 1: 707, 1981.
10. Galambos JT, Alcoholic hepatitis, in: The liver and its diseases. Schaffner F, Sherlock S, Leevy CM, Eds., Intercontinental Medical Book Corporation, NY, 1974. p. 255.
11. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L. and the VA Cooperative Study Group. Prognostic factors in alcoholic liver disease. Am J Gastroenterol 86: 210, 1991.
12. Nayak NC, Sagreiya K, Ramalingaswami V. Indian childhood cirrhosis: the nature and significance of cytoplasmic hyalin of hepatocytes. Arch Pathol 88: 631, 1969.
13. Gerber MA, Orr W, Denk H, Schaffner F, Popper H. Hepatocellular hyalin in cholestasis and cirrhosis: its diagnostic significance. Gastroenterology 64: 89, 1973.
14. Monroe S, French SW, Zamboni L. Mallory bodies in a case of primary biliary cirrhosis: an ultrastructural and morphogenetic study. Am J Clin Pathol 59: 254, 1973.
15. Schaffner F, Sternlieb I. Barka T, Popper H. Hepatocellular changes in Wilson's disease. Am J Pathol 41: 315, 1962.
16. Peters RL. Pathology of hepatocellular carcinoma, in: Hepatocellular carcinoma. Okuda K, Peters RL, Eds., John Wiley & Sons, NY, 1976, p. 107.
17. Nasrallah SM, Wills CE Jr, Galambos JT. Hepatic morphology in obesity. Dig Dis Sci 26: 325, 1981.
18. Cuellar RE, Tarter R, Hays A, Van Thiel DH. The possible occurrence of "alcoholic hepatitis" in a patient with bulimia in the absence of diagnosable alcoholism. Hepatology 7: 878, 1987.
19. Peters RL, Gay T, Reynolds TB. Post-jejunoileal bypass hepatic disease. Its similarity to alcoholic hepatic disease. Am J Clin Pathol 63: 318, 1975.
20. Hamilton DL, Vest TK, Brown BS, Shah AN, Menguy RB, Chey WY. Liver injury with alcoholic like hyalin after gastroplasty for morbid obesity. Gastroenterology 85: 722, 1983.
21. Craig RM, Neumann T, Jeejeebhoy KN, Yokoo H. Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology 79: 131, 1980.
22. Nazim M, Stamp G, Hodgson HJ. Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth. Hepatogastroenterology 36: 349, 1989.
23. Batman PA, Scheuer PJ. Diabetic hepatitis preceding the onset of glucose intolerance. Histopathology 9: 237, 1985.
24. Kimura H, Kako M, Yo K, Oda T. Alcoholic hyalins (Mallory bodies) in a case of Weber-Christian disease: electron microscopic observations of liver involvement. Gastroenterology 78: 807, 1980.
25. Simon JB, Manley PN, Brien JF, Armstrong PW. Amiodarone hepatotoxicity stimulating alcoholic liver disease. N Engl J Med 311: 167, 1984.
26. Pessayre D, Bichara M, Degott C, Potet F, Benhamou JP, Feldmann G. Perhexiline maleate-induced cirrhosis. Gastroenterology 76: 170, 1979.
27. Itoh S, Igarashi M, Tsukada Y, Ichinoe A. Nonalcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy. Acta Hepatogastroenterol 24: 415, 1977.
28. Seki K, Minami Y, Nishikawa M, et al. "Nonalcoholic steatohepatitis" induced by massive doses of synthetic estrogen. Gastroenterol Jpn 18: 197, 1983.
29. Ledwig J, Viggiano TR, McGrill DB, Ott BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434, 1980.
30. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 20: 594, 1989.
31. Conte D, Bolzoni P, Fraquelli M, Bodini P, Velio P. Non-alcoholic steatohepalitis. Report of five cases and review of the literature. Ital J Gastroenterol 27: 363, 1995.
32. Lewis D, Wainwright HC, Kew MC, Zwi S, Isaacson C. Liver damage associated with perhexiline maleate. Gut 20: 186, 1979.
33. Pieterse AS, Rowland R, Dunn D. Perhexiline maleate-induced cirrhosis. Pathology 15: 201, 1983.
34. Babany G, Mallat A, Zafrani ES, Saint-Marc Girardin MF, Carcone B, Dhumeaux D. Chronic liver disease after low daily doses of amiodarone. Report of three cases. J Hepatol 3: 228, 1986.
35. Lewis JH, Ranard RC, Caruso A, et al. Amiodarone hepatotoxicity: prevalence and clinicopathological correlations among 104 patients. Hepatology 9: 679, 1989.
36. Poucell S, Ireton J, Valeneia-Mayoral P, et al. Amiodarone-associated phospholipidosis and fibrosis of the liver: light, immunohistochemical and electron microscopic studies. Gastroenterology 86: 926, 1984.
37. Coe JE, Ishak KG, Ross MJ. Diethylstilbestrol-induced jaundice in the Chinese and Armenian hamster. Hepatology 3: 489, 1983.
38. Babany G, Uzzan F, Larrey D, et al. Alcoholic-like liver lesions induced by nifedipine. J Hepatol 9: 252, 1989.
39. Kao J-H, Chen P-J, Chen D-S. GBV-C in the aetiology of fulminant hepatitis. Lancet 347: 120, 1996.
40. Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan? Lancet 347: 908, 1996.
41. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet 347: 1552, 1996.
42. Simons JN, Pilot-Matias TJ, Leary TP et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 92: 3401, 1995.
43. Linnen J, Wages J Jr, Zhang-Keck Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271: 505, 1996.
44. Tanaka E, Alter HJ, Nakatsuji Y, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 125: 740, 1996.
45. Fiordalisi G, Zanella I, Mantero G, et al. High prevalence of GB virus C infection in a group of Italian patients with hepatitis of unknown etiology. J Infect Dis 174: 181, 1996.
46. Nalpas B, Feitelson M, Brechot C, Rubin E. Alcohol, hepatotropic viruses, and hepatocellular carcinoma. Alcohol Clin Exp Res 19: 1089, 1995.
47. Uchimura Y, Sata M, Kage M, Abe H, Tanikawa K. A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 15: 300, 1995.